NCI Concept
├── Activity (C43431) 
│   ├──  Action (C25404) 
│   │   ├──  Bathing (C86050) 
│   │   │   └── Washing and Dressing Disability 
│   │   ├──  Care (C61488) 
│   │   │   └── Usual Place of Health Care Type*
│   │   ├──  Collection (C25453) 
│   │   │   └── Biospecimen Collection Vial Type Specify Other
│   │   ├──  Defer (C79754) 
│   │   │   └── Cost Delayed Healthcare Occurrence Indicator
│   │   ├──  Exacerbation (C124138) 
│   │   │   ├── Symptom Exacerbation Occurrence Indicator
│   │   │   ├── Symptom Exacerbation Specify Other Type
│   │   │   └── Symptom Exacerbation Type
│   │   ├──  Expand (C96889) 
│   │   │   └── Sexual Orientation Expanded Status
│   │   ├──  Instruction Imperative (C64913) 
│   │   │   ├──  Clean (C65076) 
│   │   │   │   └──  Wash (C65077) 
│   │   │   │       └── Washing and Dressing Disability 
│   │   │   ├──  Schedule Frequency (C64493) 
│   │   │   │   └──  Monthly (C64498) 
│   │   │   │       ├── Pre-Pandemic Monthly Income Amount
│   │   │   │       └── Pre-Pandemic Monthly IncomeÂ Range
│   │   │   └──  Storage (C60824) 
│   │   │       └── Long-term storage temperature
│   │   ├──  Occur (C54069) 
│   │   │   └── Hospital Intensive Care Unit Admission Occurrence Indicator
│   │   ├──  Provide (C80514) 
│   │   │   └── Healthcare Setting Type
│   │   ├──  Receive (C25639) 
│   │   │   └── COVID-19 Treatment or Device Type
│   │   ├──  Reporting (C25651) 
│   │   │   └── Patient Status
│   │   ├──  Retirement (C78237) 
│   │   │   ├── Employment Status
│   │   │   └── Parent's Employment Status
│   │   ├──  Return (C71900) 
│   │   │   └── Recent Travel Date of Return in the 14 days prior to onset of symptoms or illness
│   │   ├──  Routine (C47893) 
│   │   │   └── Distance to Routine Healthcare in Miles
│   │   ├──  Share (C73624) 
│   │   │   ├── Shared Living Space Number of Individuals
│   │   │   └── Shared Living Space Person Ability to Isolate Indicator
│   │   ├──  Specify (C25685) 
│   │   │   ├── COVID-19 Vaccine Specify Other Name
│   │   │   └── Health Insurance Specify Other Type
│   │   ├──  Travel (C53462) 
│   │   │   ├──  Transportation (C141286) 
│   │   │   │   ├── Type of Transportation Used to Get to Healthcare
│   │   │   │   └── Type of Transportation Used to Get to Healthcare, Specify Other
│   │   │   ├── Recent Travel Date of Arrival in the 14 days prior to onset of symptoms or illness
│   │   │   ├── Travel Destination Country 
│   │   │   ├── Travel Destination State
│   │   │   └── Travel History in 14 days prior to onset of symptoms or illness
│   │   └──  Work (C74299) 
│   │       └── Employment Status
│   ├──  Administrative Activity (C49235) 
│   │   ├──  Form Directive (C157093) 
│   │   │   └──  Specify Other (C157106) 
│   │   │       ├── Allergen Specify Other Type
│   │   │       ├── COVID-19 Specific Medication Specify Other Type
│   │   │       ├── COVID-19 Specific Medication Specify Other Type Other COVID-19-Specific Medication, Specify:
│   │   │       ├── Healthcare Setting Specify Other Type
│   │   │       ├── Healthcare Setting Specify Other Type Specify other healthcare setting
│   │   │       ├── Patient Specify Other Status
│   │   │       ├── Patient Specify Other Status Specify other patient type
│   │   │       ├── SARS-CoV-2 Genome Variant Specify Other Name
│   │   │       ├── SARS-CoV-2 Spike Protein Mutations Specify Other Name
│   │   │       ├── Sexual Orientation Specify Other Expanded Status
│   │   │       ├── Symptom Duration After Diagnosis Specify Other Type
│   │   │       └── Symptom Duration Before Diagnosis Specify Other Type
│   │   └──  Patient Discharge (C25166) 
│   │       ├── CMS Discharge Disposition
│   │       ├── Discharge Date
│   │       ├── Discharge Diagnosis
│   │       ├── Discharge Diagnosis Specify Other
│   │       ├── Self-Report Discharge Date
│   │       ├── Self-Report Discharge Disposition*
│   │       ├── Symptom at Discharge Occurrence Indicator
│   │       ├── Symptom at Discharge Specify Other Type
│   │       └── Symptom at Discharge Type
│   ├──  Behavior (C16326) 
│   │   ├──  Personal Behavior (C19683) 
│   │   │   ├──  Informed Consent (C16735) 
│   │   │   │   ├── Informed Consent Signed Date N/A or Not Reported Indicator
│   │   │   │   ├── Informed Consent Signed Indicator
│   │   │   │   └── Informed Consent Type
│   │   │   └──  Sex Behavior (C17127) 
│   │   │       └── Sexual Orientation Status
│   │   ├── SARS-CoV-2 Risk Behavior Occurrence Indicator
│   │   └── SARS-CoV-2 Risk Behavior Type
│   ├──  Clinical or Research Activity (C16203) 
│   │   ├──  Healthcare Activity (C16205) 
│   │   │   ├──  Hospitalization (C25179) 
│   │   │   │   ├── Days Hospitalized 
│   │   │   │   ├── Hospitalization Admission Source Type
│   │   │   │   ├── Hospitalization Date*
│   │   │   │   ├── Time from COVID DX to Hospitalization
│   │   │   │   ├── Time from COVID DX to Hospitalization Unit of Measure
│   │   │   │   ├── Time from COVID Symptom Onset to Hospitalization
│   │   │   │   └── Time from COVID Symptom Onset to Hospitalization Unit of Measure
│   │   │   ├── Cost Delayed Healthcare Occurrence Indicator
│   │   │   ├── Delayed Healthcare Due to Transportation Indicator
│   │   │   ├── Employed in Healthcare Indicator
│   │   │   ├── Healthcare Setting Specify Other Type
│   │   │   ├── Healthcare Setting Type
│   │   │   ├── Healthcare Setting Used Most Often Specify Other Type
│   │   │   ├── Healthcare Setting Used Most Often Type
│   │   │   ├── Importance of Health Insurance in Seeking Care
│   │   │   ├── Other Frontline or Essential Worker Indicator
│   │   │   ├── Treating Healthcare Facility Name
│   │   │   ├── Treating Healthcare Facility Name What is the facility name where the patient was treated?
│   │   │   ├── Type of Transportation Used to Get to Healthcare
│   │   │   ├── Type of Transportation Used to Get to Healthcare, Specify Other
│   │   │   └── Usual Place of Health Care Type*
│   │   ├──  Intervention or Procedure (C25218) 
│   │   │   ├──  Diagnostic Procedure (C18020) 
│   │   │   │   ├──  Biospecimen Collection (C70945) 
│   │   │   │   │   ├── Biospecimen Collection Vial Type
│   │   │   │   │   └── Biospecimen Collection Vial Type Specify Other
│   │   │   │   ├──  Detection (C16210) 
│   │   │   │   │   └── SARS-CoV-2 Test COVID-19 Infection Detection
│   │   │   │   ├──  Diagnosis (C15220) 
│   │   │   │   │   ├── CMS Discharge Disposition
│   │   │   │   │   ├── Discharge Diagnosis
│   │   │   │   │   ├── Self-Report Discharge Disposition*
│   │   │   │   │   ├── Self-Reported COVID-19 Diagnosis Date
│   │   │   │   │   ├── Self-Reported COVID-19 Diagnosis Occurrence Indicator
│   │   │   │   │   ├── Symptom Duration After Diagnosis Type 
│   │   │   │   │   ├── Symptom Duration Before Diagnosis Type
│   │   │   │   │   └── Symptom Duration Before Diagnosis Unit of Measure
│   │   │   │   ├──  Diagnostic Imaging (C16502) 
│   │   │   │   │   ├── Chest-X-Ray Result
│   │   │   │   │   └── Date of Chest Examination
│   │   │   │   ├──  Diagnostic or Prognostic Test (C18742) 
│   │   │   │   │   └──  Research or Clinical Assessment Tool (C20993) 
│   │   │   │   │       ├──  Clinical or Research Assessment Question (C91102) 
│   │   │   │   │       │   └──  CPTAC Questions (C158612) 
│   │   │   │   │       │       └──  Other Medication (C159287) 
│   │   │   │   │       │           ├── COVID-19 Specific Medication Specify Other Type
│   │   │   │   │       │           ├── COVID-19 Specific Medication Specify Other Type Other COVID-19-Specific Medication, Specify:
│   │   │   │   │       │           ├── Concomitant Medication Name
│   │   │   │   │       │           └── Concomitant Medication Name Other medications, taken than those taken to treat COVID- 19?
│   │   │   │   │       └──  Self-Report (C74528) 
│   │   │   │   │           ├──  Patient Self-Report (C21089) 
│   │   │   │   │           │   ├── Self-Reported COVID-19 Diagnosis Date
│   │   │   │   │           │   └── Self-Reported COVID-19 Diagnosis Occurrence Indicator
│   │   │   │   │           ├── Self-Report Discharge Date
│   │   │   │   │           ├── Self-Report Discharge Disposition*
│   │   │   │   │           ├── Self-Reported COVID-19 Symptom Dizziness Confirmed by Heart Rate and Blood Pressure Indicator
│   │   │   │   │           ├── Self-Reported COVID-19 Symptom Occurrence Indicator
│   │   │   │   │           ├── Self-Reported COVID-19 Symptom Onset Date Indicator
│   │   │   │   │           ├── Self-Reported COVID-19 Symptom Onset Date*
│   │   │   │   │           └── Self-Reported COVID-19 Symptom Type*
│   │   │   │   ├──  Medical Examination (C25305) 
│   │   │   │   │   └──  Physical Examination (C20989) 
│   │   │   │   │       ├── Physical Exam Date
│   │   │   │   │       ├── Physical Exam Date Indicator
│   │   │   │   │       ├── Physical Exam Findings/Sign Occurrence Indicator
│   │   │   │   │       ├── Physical Exam Findings/Sign Specify Other Type
│   │   │   │   │       └── Physical Exam Findings/Sign Type*
│   │   │   │   └──  Observation (C25598) 
│   │   │   │       └──  Vital Signs Measurement (C49672) 
│   │   │   │           ├── Vital Signs Date and Time
│   │   │   │           ├── Vital Signs Measurement
│   │   │   │           ├── Vital Signs Measurement Occurrence Indicator
│   │   │   │           ├── Vital Signs Specify Other Timepoint
│   │   │   │           ├── Vital Signs Timepoint
│   │   │   │           ├── Vital Signs Type*
│   │   │   │           └── Vital Signs Unit Of Measure
│   │   │   ├──  Laboratory Procedure (C25294) 
│   │   │   │   └── Lab Result Not Done Occurrence Indicator
│   │   │   └──  Therapeutic Procedure (C49236) 
│   │   │       ├──  Adverse Event Treatment (C88082) 
│   │   │       │   └── Adverse Event Related to Study Treatment Indicator
│   │   │       ├──  Oxygen Therapy (C94624) 
│   │   │       │   └── Supplemental Oxygen Occurrence Indicator
│   │   │       └──  Pharmacologic Management (C21090) 
│   │   │           ├──  Current Medication (C156818) 
│   │   │           │   └── Current Medication Name
│   │   │           └──  Pharmacotherapy Discontinuation (C128535) 
│   │   │               ├── COVID-19 Medication Pre-mature Discontinuation Reason
│   │   │               ├── COVID-19 Medication Pre-mature Discontinuation Reason Reason medication was discontinued, select all that apply.
│   │   │               ├── COVID-19 Medication Pre-mature Discontinuation Specify Other Reason
│   │   │               └── COVID-19 Medication Pre-mature Discontinuation Specify Other Reason Specify other reason medication was discontinued pre-maturely
│   │   └──  Research Activity (C15429) 
│   │       ├──  Study (C63536) 
│   │       │   └── Adverse Event Related to Study Treatment Indicator
│   │       └──  Testing (C15336) 
│   │           ├── COVID-19 Symptoms At Time of Testing Indicator
│   │           ├── Home SARS-CoV-2 Test Name
│   │           ├── Home SARS-CoV-2 Test Specify Other Name
│   │           ├── Hospitalized at Time of Testing Occurrence Indicator
│   │           ├── SARS-CoV-2 Test COVID-19 Infection Detection
│   │           ├── SARS-CoV-2 Test Date and Time
│   │           ├── SARS-CoV-2 Test Date of Result
│   │           ├── SARS-CoV-2 Test Manufacturer Name
│   │           ├── SARS-CoV-2 Test Manufacturer Specify Other Name
│   │           ├── SARS-CoV-2 Test Specify Other Processing Location Type
│   │           ├── SARS-CoV-2 Test Specify Other Specimen Collection Location Type
│   │           ├── SARS-CoV-2 Test Specimen Collection Location Type
│   │           ├── SARS-CoV-2 Test Type
│   │           └── SARS-CoV-2 Tested Occurrence Indicator
│   ├──  Physical Activity (C17708) 
│   │   └──  Activity of Daily Living (C53291) 
│   │       └──  Housework (C98072) 
│   │           ├── Employment Status
│   │           └── Parent's Employment Status
│   └──  Technique (C16847) 
│       └──  Research Technique (C20368) 
│           └──  Biomolecule Separation Technology (C18653) 
│               └──  Chromatography (C16431) 
│                   ├── Chromatography Method Specify Other Type
│                   ├── Chromatography Method Type 
│                   └── Chromatography Method Type 
├── Biological Process (C17828) 
│   └──  Organismal Process (C19988) 
│       └──  Neurologic Process (C21074) 
│           └──  Mental Process (C16840) 
│               ├──  Attention Concentration (C41209) 
│               │   └── Concentration Disability 
│               ├──  Confidence (C43367) 
│               │   └── Confidence with Health Forms
│               ├──  Feelings (C77965) 
│               │   └──  Indecision (C95495) 
│               │       └── Concentration Disability 
│               └──  Recollect (C122669) 
│                   └── Concentration Disability 
├── Conceptual Entity (C20181) 
│   ├──  Agent (C1708) 
│   │   ├──  Medication (C459) 
│   │   │   ├── COVID-19 Medication Pre-mature Discontinuation Reason
│   │   │   ├── COVID-19 Medication Pre-mature Discontinuation Reason Reason medication was discontinued, select all that apply.
│   │   │   ├── COVID-19 Medication Pre-mature Discontinuation Specify Other Reason
│   │   │   ├── COVID-19 Medication Pre-mature Discontinuation Specify Other Reason Specify other reason medication was discontinued pre-maturely
│   │   │   ├── COVID-19 Specific Medication Specify Other Type
│   │   │   ├── COVID-19 Specific Medication Specify Other Type Other COVID-19-Specific Medication, Specify:
│   │   │   ├── COVID-19 Specific Medication Type
│   │   │   ├── COVID-19 Specific Medication Type
│   │   │   ├── COVID-19 Specific Medication Type What medications did the patient take to treat COVID-19?
│   │   │   ├── Concomitant Medication Name
│   │   │   ├── Concomitant Medication Name Other medications, taken than those taken to treat COVID- 19?
│   │   │   ├── Concomitant Medication Name*
│   │   │   ├── Current Medication Dose
│   │   │   ├── Current Medication Dose For each medication, specify dose
│   │   │   ├── Current Medication Dose Frequency
│   │   │   ├── Current Medication Dose Frequency For each medication, specify frequency
│   │   │   ├── Current Medication Dose Unit of Measure
│   │   │   ├── Current Medication Dose Unit of Measure For each medication, specify unit of measure
│   │   │   ├── Medication Discontinued Date
│   │   │   ├── Medication Discontinued Date Unknown Indicator
│   │   │   ├── Medication Discontinued Date Unknown Indicator Was the date when the medication was discontinued unknown?
│   │   │   └── Medication Discontinued Date What date was the medication prematurely discontinued?
│   │   ├──  Metabolite (C61154) 
│   │   │   ├── Major Classes of Metabolites Examined
│   │   │   ├── Metabolite Analysis Type
│   │   │   ├── Metabolite Class Examined Specify Other
│   │   │   └── Metabolite High level techniques used for identification
│   │   └──  Over the Counter Product (C54068) 
│   │       └── Current Medication Name
│   ├──  Code (C25162) 
│   │   ├──  Country Code (C20108) 
│   │   │   └── Travel Destination Country 
│   │   └──  Postal Code (C25621) 
│   │       └── Address Postal Code
│   ├──  Consent (C25460) 
│   │   └── Informed Consent Type
│   ├──  Criterion (C25466) 
│   │   └── Common Terminology Criteria for Adverse Events Version 4.0 Low Level Term Name
│   ├──  Data Element (C41002) 
│   │   └──  Measurement Unit Description (C92571) 
│   │       └──  Original Result Unit (C82586) 
│   │           └──  Laboratory Test Original Result Unit (C83106) 
│   │               └── Lab Result Unit of Measure
│   ├──  Decision (C53285) 
│   │   └── Importance of Health Insurance in Seeking Care
│   ├──  Difficulty (C62189) 
│   │   ├── Daily Activities Disability
│   │   └── Washing and Dressing Disability 
│   ├──  Domain (C62289) 
│   │   └──  Submission Domain (C49556) 
│   │       └──  Clinical Events Domain (C85441) 
│   │           └── Lab Result Date
│   ├──  Event (C25499) 
│   │   └──  Occurrence (C25275) 
│   │       ├── Cost Delayed Healthcare Occurrence Indicator
│   │       ├── SARS-CoV-2 Risk Behavior Occurrence Indicator
│   │       ├── SARS-CoV-2 Spike Protein Mutations Occurrence Indicator
│   │       └── Self-Reported COVID-19 Symptom Occurrence Indicator
│   ├──  Experience (C54627) 
│   │   └── Self-Reported COVID-19 Symptom Type*
│   ├──  Facility (C62574) 
│   │   └──  Clinical or Research Facility (C38186) 
│   │       └──  Laboratory (C37984) 
│   │           ├── Lab Result Specify Other Type
│   │           └── Lab Result Value
│   ├──  Factor (C25506) 
│   │   └──  Aggravating Factor (C94433) 
│   │       └── Symptom Exacerbation Specify Other Type
│   ├──  Geographic Area (C16632) 
│   │   ├──  City (C25160) 
│   │   │   └── Address City Name
│   │   ├──  County (C49292) 
│   │   │   ├── Address County Name
│   │   │   └── Address County Name
│   │   ├──  Living Quarters (C86029) 
│   │   │   └──  Residence (C25273) 
│   │   │       └── Years at Residence
│   │   ├──  Sites of Care Delivery (C19696) 
│   │   │   ├──  Healthcare Facility (C21541) 
│   │   │   │   ├──  Clinics and Hospitals (C19326) 
│   │   │   │   │   └──  Hospital (C16696) 
│   │   │   │   │       ├── Distance to Routine Healthcare in Miles
│   │   │   │   │       └── Distance to Testing in Miles
│   │   │   │   ├──  Intensive Care Unit (C53511) 
│   │   │   │   │   ├── Days in Intensive Care Unit 
│   │   │   │   │   └── Hospital Intensive Care Unit Admission Occurrence Indicator
│   │   │   │   ├── Distance to Routine Healthcare in Miles
│   │   │   │   ├── Distance to Testing in Miles
│   │   │   │   ├── Healthcare Setting Specify Other Type
│   │   │   │   ├── Healthcare Setting Specify Other Type Specify other healthcare setting
│   │   │   │   ├── Treating Healthcare Facility Name
│   │   │   │   ├── Treating Healthcare Facility Name What is the facility name where the patient was treated?
│   │   │   │   ├── Type of Transportation Used to Get to Healthcare
│   │   │   │   └── Type of Transportation Used to Get to Healthcare, Specify Other
│   │   │   └──  Worksite (C17556) 
│   │   │       └── Telework Eligibility Status
│   │   └──  State (C87194) 
│   │       ├──  US State (C30010) 
│   │       │   └── Birthplace US State
│   │       ├── Address State Code
│   │       ├── Address State Code
│   │       └── Travel Destination State
│   ├──  Group (C43359) 
│   │   └──  Population Group (C17005) 
│   │       ├──  Age Group (C20587) 
│   │       │   ├──  Adult (C17600) 
│   │       │   │   └── Shared Living Space Number of Individuals
│   │       │   └──  Child (C16423) 
│   │       │       └── Shared Living Space Number of Individuals
│   │       ├──  Ethnic Group (C16564) 
│   │       │   ├── Ancestry
│   │       │   ├── Ethnicity*
│   │       │   └── Ethnicity*
│   │       ├──  Personnel (C60758) 
│   │       │   └──  Research Personnel (C17089) 
│   │       │       └──  Employer (C54144) 
│   │       │           └── Ability to Find Equivalent Job
│   │       ├──  Professional Organization or Group (C19711) 
│   │       │   └──  Centers for Medicare and Medicaid Services (C95516) 
│   │       │       └── CMS Discharge Disposition
│   │       ├──  Race (C17049) 
│   │       │   ├── Race
│   │       │   └── Race*
│   │       └──  Social Group (C18230) 
│   │           └──  Household (C41194) 
│   │               ├── Pre-Pandemic Monthly Income Amount
│   │               ├── Pre-Pandemic Monthly IncomeÂ Range
│   │               └── Shared Living Space Person Ability to Isolate Indicator
│   ├──  History (C54625) 
│   │   ├──  Personal Medical History (C18772) 
│   │   │   └──  Other Personal Medical History (C53263) 
│   │   │       └──  History of Medication (C168253) 
│   │   │           ├── COVID-19 Specific Medication Type
│   │   │           └── COVID-19 Specific Medication Type What medications did the patient take to treat COVID-19?
│   │   └──  Social History (C81292) 
│   │       └──  Travel History (C173619) 
│   │           └── Travel History in 14 days prior to onset of symptoms or illness
│   ├──  Indicator (C25180) 
│   │   └──  Event Occurrence Indicator (C82438) 
│   │       ├──  Adverse Event Ongoing (C83051) 
│   │       │   └── Adverse Event Ongoing Indicator
│   │       └──  Test Occurrence (C82525) 
│   │           └── SARS-CoV-2 Tested Occurrence Indicator
│   ├──  Insecurity (C171543) 
│   │   └──  Job Insecurity (C171544) 
│   │       └── Job Insecurity in 12 Months
│   ├──  Intellectual Property (C97331) 
│   │   ├──  Classification (C25161) 
│   │   │   ├──  Adverse Event Classification (C48276) 
│   │   │   │   └──  Common Terminology Criteria for Adverse Events (C49704) 
│   │   │   │       └── Common Terminology Criteria for Adverse Events Version 4.0 Low Level Term Name
│   │   │   ├──  Class (C25346) 
│   │   │   │   └── Major Classes of Metabolites Examined
│   │   │   ├── COVID-19 Case Classification
│   │   │   └── COVID-19 Case Classification Date
│   │   └──  Document (C19498) 
│   │       ├──  Address (C25407) 
│   │       │   ├── Address City Name
│   │       │   ├── Address County Name
│   │       │   ├── Address Line 1
│   │       │   ├── Address Line 2
│   │       │   ├── Address Postal Code
│   │       │   ├── Address State Code
│   │       │   ├── Full Residential Address*
│   │       │   └── Years at Residence
│   │       ├──  Advance Directive (C93142) 
│   │       │   └──  Do Not Resuscitate Order (C93313) 
│   │       │       └── New or revised end of life instructions (DNR)?during hospitalization?Indicator
│   │       ├──  Form (C19464) 
│   │       │   └── Confidence with Health Forms
│   │       ├──  Identifier (C25364) 
│   │       │   └──  Unique Identifier (C70663) 
│   │       │       └── Unique ID
│   │       ├──  Medical Order (C177532) 
│   │       │   └──  Physician Orders for Life Sustaining Treatment (C176984) 
│   │       │       └── Physician Orders for Life Sustaining Treatment (POLST) Indicator
│   │       └──  Signature (C25678) 
│   │           └── Informed Consent Signed Date
│   ├──  Investigation Finding (C61036) 
│   │   └── Ability to Find Equivalent Job
│   ├──  Language (C16779) 
│   │   └──  Spoken Language (C51277) 
│   │       ├──  Indo-European Language (C160962) 
│   │       │   └──  Germanic Language (C161904) 
│   │       │       └──  West Germanic Language (C160956) 
│   │       │           └──  English Language (C82847) 
│   │       │               └── English Proficiency Level
│   │       └── Primary Language Spoken at home?
│   ├──  Material (C48187) 
│   │   └──  Specimen (C19157) 
│   │       ├──  Biospecimen (C70699) 
│   │       │   ├── Aliquot volume in mL
│   │       │   ├── Metabolomics Biospecimen Specify Other Type
│   │       │   ├── Metabolomics Biospecimen Type
│   │       │   └── Minutes until sample collected reaches the freezer 
│   │       ├── SARS-CoV-2 Test Specify Other Specimen Collection Location Type
│   │       ├── Sample Collection Date
│   │       ├── Sample Collection Date
│   │       └── Sample Collection Time
│   ├──  Means (C47955) 
│   │   └──  Method (C71460) 
│   │       ├──  Method Of Identification (C90422) 
│   │       │   └── Metabolite High level techniques used for identification
│   │       └──  Test Method (C82535) 
│   │           └── Chromatography Method Type 
│   ├──  Miscellaneous Molecular Biology Terms (C19896) 
│   │   ├──  Genome Variation (C179559) 
│   │   │   ├── SARS-CoV-2 Genome Variant Name
│   │   │   ├── SARS-CoV-2 Genome Variant Occurrence Indicator
│   │   │   └── SARS-CoV-2 Genome Variant Specify Other Name
│   │   └──  Rh Factor (C67517) 
│   │       └── Blood Type
│   ├──  Name (C42614) 
│   │   └──  Person Name (C25191) 
│   │       ├──  First Name (C40974) 
│   │       │   └── First Name
│   │       ├──  Last Name (C40975) 
│   │       │   └── Last Name
│   │       ├──  Middle Name (C188268)
│   │       │   └── Middle Name
│   │       └── Full Name
│   ├──  Need (C41204) 
│   │   ├── Cost Delayed Healthcare Occurrence Indicator
│   │   └── Usual Place of Health Care Type*
│   ├──  Occupation or Discipline (C19160) 
│   │   ├──  Occupation (C25193) 
│   │   │   ├──  Miscellaneous Occupation (C20192) 
│   │   │   │   ├──  Manufacturer (C25392) 
│   │   │   │   │   ├── SARS-CoV-2 Test Manufacturer Name
│   │   │   │   │   └── SARS-CoV-2 Test Manufacturer Specify Other Name
│   │   │   │   └──  Student (C75561) 
│   │   │   │       ├── Employment Status
│   │   │   │       └── Parent's Employment Status
│   │   │   └── Ability to Find Equivalent Job
│   │   ├──  Social Sciences (C17141) 
│   │   │   └──  Economics (C61331) 
│   │   │       └──  Medical Economics (C16527) 
│   │   │           └──  Insurance and Payment Issues (C18928) 
│   │   │               └──  Insurance (C16745) 
│   │   │                   └──  Health Insurance (C157356) 
│   │   │                       ├── Health Insurance Specify Other Type
│   │   │                       ├── Health Insurance Type
│   │   │                       └── Importance of Health Insurance in Seeking Care
│   │   └──  Technology (C17187) 
│   │       └──  Information Sciences (C16733) 
│   │           └──  Informatics (C18145) 
│   │               └──  Bioinformatics (C17964) 
│   │                   └──  Metabolomics (C49019) 
│   │                       ├── Aliquot volume in mL
│   │                       ├── Biospecimen Collection Vial Type
│   │                       ├── Biospecimen Collection Vial Type Specify Other
│   │                       ├── Chromatography Method Specify Other Type
│   │                       ├── Chromatography Method Type 
│   │                       ├── Metabolomics Biospecimen Specify Other Type
│   │                       ├── Metabolomics Biospecimen Type
│   │                       ├── Metabolomics Platform Specify Other Type
│   │                       ├── Metabolomics Platform Type
│   │                       ├── Metabolomics Quality Control Measures
│   │                       ├── Metabolomics Quality Control Measures Occurrence Indicator
│   │                       └── Overall Metabolomics Findings
│   ├──  Outcome (C20200) 
│   │   ├──  Dead (C28554) 
│   │   │   └── COVID-19 Related Death Indicator
│   │   └──  Experimental Result (C76125) 
│   │       ├── Lab Result Not Done Occurrence Indicator
│   │       ├── SARS-CoV-2 Test Date of Result
│   │       └── SARS-CoV-2 Test Overall Result
│   ├──  Person (C25190) 
│   │   ├──  Family Member (C41256) 
│   │   │   └──  Relative (C21480) 
│   │   │       └──  Parent (C42709) 
│   │   │           └── Parent's Current Educational Attainment
│   │   ├──  Frontline Essential Worker (C179413) 
│   │   │   ├── Frontline or Essential Worker Category
│   │   │   └── Other Frontline or Essential Worker Indicator
│   │   ├──  Member (C25368) 
│   │   │   └──  Household Member (C132449) 
│   │   │       └── Shared Living Space Person Ability to Isolate Indicator
│   │   ├──  Patient (C16960) 
│   │   │   ├── Date of Birth*
│   │   │   └── Employed in Healthcare Indicator
│   │   └── Ancestry
│   ├──  Provider (C37900) 
│   │   ├── Distance to Routine Healthcare in Miles
│   │   └── Distance to Testing in Miles
│   ├──  Relationship (C25648) 
│   │   └── Adverse Event Related to Study Treatment Indicator
│   ├──  Risk (C17102) 
│   │   ├── SARS-CoV-2 Risk Behavior Occurrence Indicator
│   │   └── SARS-CoV-2 Risk Behavior Type
│   ├──  Social Circumstances (C20188) 
│   │   └──  Socioeconomic Factors (C17468) 
│   │       ├──  Education Level (C17953) 
│   │       │   ├── Current Educational Attainment
│   │       │   ├── Current Educational Attainment
│   │       │   └── Parent's Current Educational Attainment
│   │       └──  Income (C41150) 
│   │           ├── Ability to Find Equivalent Job
│   │           ├── Pre-Pandemic Monthly Income Amount
│   │           └── Pre-Pandemic Monthly IncomeÂ Range
│   ├──  Source (C25683) 
│   │   └── Pre-Pandemic Monthly Income Amount
│   ├──  Strategy (C147914) 
│   │   └──  Mitigation Strategy (C173767) 
│   │       ├── SARS-CoV-2 Mitigation Strategy Frequent Adherence Occurrence
│   │       ├── SARS-CoV-2 Mitigation Strategy Specify Other Type
│   │       └── SARS-CoV-2 Mitigation Strategy Type
│   ├──  Supplement (C68641) 
│   │   ├── Current Medication Name
│   │   └── Supplemental Oxygen Occurrence Indicator
│   ├──  Target (C25702) 
│   │   ├── Travel Destination Country 
│   │   └── Travel Destination State
│   ├──  Terminology Entity (C42698) 
│   │   ├──  Linguistic Form (C84268) 
│   │   │   └──  Term (C45559) 
│   │   │       └──  MedDRA Low Level Term (C71886) 
│   │   │           └── Common Terminology Criteria for Adverse Events Version 4.0 Low Level Term Name
│   │   └──  Nomenclature (C48298) 
│   │       └── Common Terminology Criteria for Adverse Events Version 4.0 Low Level Term Name
│   └──  Version (C25714) 
│       └──  Technology Platform Version (C45378) 
│           ├── Metabolomics Platform Specify Other Type
│           └── Metabolomics Platform Type
├── Disease, Disorder or Finding (C7057) 
│   ├──  Disease or Disorder (C2991) 
│   │   ├──  Disorder by Site (C27551) 
│   │   │   └──  Immune System and Related Disorders (C27351) 
│   │   │       └──  Immune System Disorder (C3507) 
│   │   │           └──  Hypersensitivity (C3114) 
│   │   │               └──  Allergic Reaction (C114476) 
│   │   │                   └── Allergen Type
│   │   ├──  Non-Neoplastic Disorder (C53529) 
│   │   │   └──  Non-Neoplastic Disorder by Special Category (C53547) 
│   │   │       ├──  Congenital or Acquired Anatomic Abnormality (C36287) 
│   │   │       │   └──  Congenital Abnormality (C2849) 
│   │   │       │       └── Adverse Event Due to Congenital Anomaly Indicator
│   │   │       ├──  Epidemic Disorder (C171452) 
│   │   │       │   └──  Pandemic Disorder (C171519) 
│   │   │       │       ├── Pre-Pandemic Monthly Income Amount
│   │   │       │       └── Pre-Pandemic Monthly IncomeÂ Range
│   │   │       └──  Inflammatory Disorder (C93210) 
│   │   │           └──  Infectious Disorder (C26726) 
│   │   │               └──  Viral Infection (C3439) 
│   │   │                   └──  Coronavirus Infection (C181757) 
│   │   │                       └──  COVID-19 Infection (C171133) 
│   │   │                           ├── COVID-19 Mental Health Symptom Type*
│   │   │                           ├── COVID-19 Psychosocial Symptom Occurrence Indicator
│   │   │                           ├── COVID-19 Specific Medications Occurrence Indicator
│   │   │                           ├── COVID-19 Symptoms At Time of Testing Indicator
│   │   │                           ├── COVID-19 Vaccine Name
│   │   │                           ├── COVID-19 Vaccine Specify Other Name
│   │   │                           ├── Quality of Life (QOL) Rating
│   │   │                           ├── SARS-CoV-2 Impact on Health Finding Type
│   │   │                           ├── SARS-CoV-2 Test COVID-19 Infection Detection
│   │   │                           ├── SARS-CoV-2 Tested Occurrence Indicator
│   │   │                           ├── Self-Reported COVID-19 Symptom Dizziness Confirmed by Heart Rate and Blood Pressure Indicator
│   │   │                           ├── Self-Reported COVID-19 Symptom Occurrence Indicator
│   │   │                           ├── Self-Reported COVID-19 Symptom Onset Date Indicator
│   │   │                           ├── Self-Reported COVID-19 Symptom Onset Date*
│   │   │                           └── Self-Reported COVID-19 Symptom Type*
│   │   └── Comorbidity or Underlying Condition Specify Other Type
│   └──  Finding (C3367) 
│       ├──  Clinical Test Result (C77140) 
│       │   ├──  Abnormal Chest Radiograph (C168098) 
│       │   │   └── Chest-X-Ray Result
│       │   ├──  Laboratory Test Result (C36292) 
│       │   │   ├── Lab Result Specify Other Type
│       │   │   ├── Lab Result Type
│       │   │   ├── Lab Result Value
│       │   │   ├── SARS-CoV-2 Test COVID-19 Infection Detection
│       │   │   └── SARS-CoV-2 Test Date of Result
│       │   └── SARS-CoV-2 Test Date of Result
│       ├──  Finding by Cause (C36291) 
│       │   ├──  Adverse Event (C41331) 
│       │   │   ├──  Adverse Event by CTCAE Category (C53781) 
│       │   │   │   └──  Adverse Event Associated with the Nervous System (C53808) 
│       │   │   │       └──  Dizziness, CTCAE 3.0 (C55385) 
│       │   │   │           └── Self-Reported COVID-19 Symptom Dizziness Confirmed by Heart Rate and Blood Pressure Indicator
│       │   │   ├──  Adverse Event by Severity (C52680) 
│       │   │   │   └──  Adverse Event Severity Grade (C166200) 
│       │   │   │       └── Adverse Event Severity Grade
│       │   │   ├── Adverse Event Due to Congenital Anomaly Indicator
│       │   │   └── Common Terminology Criteria for Adverse Events Version 4.0 Low Level Term Name
│       │   ├──  Complication (C2959) 
│       │   │   ├── COVID-19 Complication
│       │   │   ├── COVID-19 Complication Occurrence
│       │   │   ├── COVID-19 Complication Onset Date
│       │   │   └── COVID-19 Complication Other
│       │   └──  Infection (C128320) 
│       │       ├──  Co-infection (C173511) 
│       │       │   └── Coinfection Present
│       │       └──  Superinfection (C177386) 
│       │           └── Superinfection Present
│       ├──  Finding by Site or System (C36278) 
│       │   ├──  Cardiovascular System Finding (C35552) 
│       │   │   └──  Blood Pressure Finding (C54707) 
│       │   │       └── Self-Reported COVID-19 Symptom Dizziness Confirmed by Heart Rate and Blood Pressure Indicator
│       │   └──  Reproductive System Finding (C36284) 
│       │       └──  Female Reproductive System Finding (C117720) 
│       │           └──  Pregnancy Finding (C92720) 
│       │               └──  Pregnancy Status (C69218) 
│       │                   └──  Pregnant (C124295) 
│       │                       ├── Current Pregnancy Due Date
│       │                       └── Current Pregnancy Indicator
│       └──  Sign or Symptom (C100104) 
│           ├──  Sign (C53458) 
│           │   └──  Fever (C3038) 
│           │       ├── Fever Duration
│           │       └── Fever Duration
│           ├──  Symptom (C4876) 
│           │   ├──  Sickness (C107499) 
│           │   │   ├── Self-Reported COVID-19 Symptom Type*
│           │   │   ├── Symptom Exacerbation Type
│           │   │   └── Usual Place of Health Care Type*
│           │   ├── COVID-19 Psychosocial Symptom Occurrence Indicator
│           │   ├── COVID-19 Symptoms At Time of Testing Indicator
│           │   ├── Self-Reported COVID-19 Symptom Dizziness Confirmed by Heart Rate and Blood Pressure Indicator
│           │   ├── Self-Reported COVID-19 Symptom Occurrence Indicator
│           │   ├── Self-Reported COVID-19 Symptom Onset Date*
│           │   ├── Self-Reported COVID-19 Symptom Type*
│           │   ├── Symptom Duration After Diagnosis Type 


│           │   ├── Symptom Duration After Diagnosis Value
│           │   ├── Symptom Duration Before Diagnosis Type
│           │   ├── Symptom Exacerbation Occurrence Indicator
│           │   ├── Symptom Exacerbation Specify Other Type
│           │   ├── Symptom Exacerbation Type
│           │   ├── Symptom at Discharge Occurrence Indicator
│           │   ├── Symptom at Discharge Specify Other Type
│           │   └── Symptom at Discharge Type
│           └──  Vital Signs (C154628) 
│               ├── Vital Signs Date and Time
│               ├── Vital Signs Measurement
│               ├── Vital Signs Measurement Occurrence Indicator
│               ├── Vital Signs Specify Other Timepoint
│               ├── Vital Signs Timepoint
│               ├── Vital Signs Type*
│               └── Vital Signs Unit Of Measure
├── Drug, Food, Chemical or Biomedical Material (C1908) 
│   ├──  Chemical Modifier (C1932) 
│   │   └──  Allergen (C62651) 
│   │       ├── Allergen Specify Other Type
│   │       └── Allergen Type
│   ├──  Drug or Chemical by Structure (C1913) 
│   │   └──  Inorganic Chemical (C579) 
│   │       └──  Element (C1940) 
│   │           └──  Oxygen (C722) 
│   │               └── Supplemental Oxygen Occurrence Indicator
│   └──  Pharmacologic Substance (C1909) 
│       └──  Immunotherapeutic Agent (C308) 
│           └──  Vaccine (C923) 
│               ├──  COVID-19 Vaccine (C173023) 
│               │   └── COVID-19 Vaccine Receptivity Status
│               └──  Viral Vaccine (C96404) 
│                   └──  Recombinant Viral Vaccine (C1572) 
│                       └──  Vaccinia Vaccine (C2313) 
│                           ├── COVID-19 Vaccine Name
│                           └── COVID-19 Vaccine Specify Other Name
├── Gene Product (C26548) 
│   └──  Protein (C17021) 
│       └──  Protein, Organized by Origin (C20032) 
│           └──  Non-Human Protein (C20158) 
│               └──  Viral Protein (C17254) 
│                   └──  SARS-CoV-2 Spike Glycoprotein (C178209) 
│                       ├── SARS-CoV-2 Spike Protein Mutations Name
│                       ├── SARS-CoV-2 Spike Protein Mutations Occurrence Indicator
│                       └── SARS-CoV-2 Spike Protein Mutations Specify Other Name
├── Manufactured Object (C97325) 
│   └──  Diagnostic, Therapeutic, or Research Equipment (C19238) 
│       ├──  Corrective Lens (C87188) 
│       │   └──  Glasses (C87148) 
│       │       └── Vision Disability 
│       ├──  Device (C62103) 
│       │   ├──  Medical Device (C16830) 
│       │   │   └──  Package Type (C43164) 
│       │   │       └──  Vial (C41275) 
│       │   │           ├── Biospecimen Collection Vial Type
│       │   │           └── Biospecimen Collection Vial Type Specify Other
│       │   ├── COVID-19 Treatment or Device Occurrence Indicator
│       │   ├── COVID-19 Treatment or Device Specify Other Type
│       │   └── COVID-19 Treatment or Device Type
│       └──  Instrumentation (C16742) 
│           └──  Freezer (C84327) 
│               └── Minutes until sample collected reaches the freezer 
├── Molecular Abnormality (C3910) 
│   └──  Molecular Sequence Variation (C97926) 
│       └──  Molecular Genetic Variation (C36391) 
│           └──  Mutation Abnormality (C45576) 
│               └──  Gene Mutation (C18093) 
│                   ├── SARS-CoV-2 Spike Protein Mutations Name
│                   ├── SARS-CoV-2 Spike Protein Mutations Occurrence Indicator
│                   └── SARS-CoV-2 Spike Protein Mutations Specify Other Name
├── Organism (C14250) 
│   └──  Virus (C14283) 
│       └──  RNA Virus (C14269) 
│           └──  Positive Sense ssRNA Virus (C14351) 
│               └──  Coronaviridae (C113205) 
│                   └──  Coronavirus (C26431) 
│                       ├──  Betacoronavirus (C113207) 
│                       │   └──  SARS Coronavirus 2 (C169076) 
│                       │       ├── COVID-19 Case Classification
│                       │       ├── COVID-19 Case Classification Date
│                       │       ├── COVID-19 Complication
│                       │       ├── COVID-19 Complication Occurrence
│                       │       ├── COVID-19 Complication Onset Date
│                       │       ├── COVID-19 Complication Onset Date Indicator
│                       │       ├── COVID-19 Complication Other
│                       │       ├── COVID-19 Disease Severity
│                       │       ├── COVID-19 Medication Pre-mature Discontinuation Reason
│                       │       ├── COVID-19 Medication Pre-mature Discontinuation Reason Reason medication was discontinued, select all that apply.
│                       │       ├── COVID-19 Medication Pre-mature Discontinuation Specify Other Reason
│                       │       ├── COVID-19 Medication Pre-mature Discontinuation Specify Other Reason Specify other reason medication was discontinued pre-maturely
│                       │       ├── COVID-19 Reinfection Present
│                       │       ├── COVID-19 Related Death Indicator
│                       │       ├── COVID-19 Specific Medication Specify Other Type
│                       │       ├── COVID-19 Specific Medication Specify Other Type Other COVID-19-Specific Medication, Specify:
│                       │       ├── COVID-19 Specific Medication Type
│                       │       ├── COVID-19 Specific Medication Type
│                       │       ├── COVID-19 Specific Medication Type What medications did the patient take to treat COVID-19?
│                       │       ├── Concomitant Medication Name
│                       │       ├── Concomitant Medication Name Other medications, taken than those taken to treat COVID- 19?
│                       │       ├── Concomitant Medication Name*
│                       │       ├── Home SARS-CoV-2 Test Name
│                       │       ├── Home SARS-CoV-2 Test Specify Other Name
│                       │       ├── Overall Metabolomics Findings
│                       │       ├── SARS-CoV-2 Genome Variant Name
│                       │       ├── SARS-CoV-2 Genome Variant Occurrence Indicator
│                       │       ├── SARS-CoV-2 Genome Variant Specify Other Name
│                       │       ├── SARS-CoV-2 Impact on Health Finding Type
│                       │       ├── SARS-CoV-2 Impact on Healthcare Utilization Type
│                       │       ├── SARS-CoV-2 Risk Behavior Occurrence Indicator
│                       │       ├── SARS-CoV-2 Risk Behavior Type
│                       │       ├── SARS-CoV-2 Test COVID-19 Infection Detection
│                       │       ├── SARS-CoV-2 Test COVID-19 Infection Detection
│                       │       ├── SARS-CoV-2 Test Date and Time
│                       │       ├── SARS-CoV-2 Test Date and Time Indicator
│                       │       ├── SARS-CoV-2 Test Date of Result
│                       │       ├── SARS-CoV-2 Test Date of Result
│                       │       ├── SARS-CoV-2 Test Manufacturer Name
│                       │       ├── SARS-CoV-2 Test Manufacturer Specify Other Name
│                       │       ├── SARS-CoV-2 Test Overall Result
│                       │       ├── SARS-CoV-2 Test Processing Location Type
│                       │       ├── SARS-CoV-2 Test Specify Other Processing Location Type
│                       │       ├── SARS-CoV-2 Test Specify Other Specimen Collection Location Type
│                       │       ├── SARS-CoV-2 Test Specimen Collection Location Type
│                       │       ├── SARS-CoV-2 Test Type
│                       │       ├── SARS-CoV-2 Test Type
│                       │       ├── SARS-CoV-2 Tested Occurrence Indicator
│                       │       ├── SARS-CoV-2 Tested Occurrence Indicator
│                       │       ├── Self-Reported COVID-19 Diagnosis Date
│                       │       └── Self-Reported COVID-19 Diagnosis Occurrence Indicator
│                       ├── Pre-Pandemic Monthly Income Amount
│                       └── Pre-Pandemic Monthly IncomeÂ Range
└── Property or Attribute (C20189) 
    ├──  Characteristic (C25447) 
    │   ├──  Population Group Characteristic (C171088) 
    │   │   └──  Demographics (C16495) 
    │   │       └──  Comorbidity (C16457) 
    │   │           ├── Comorbidity or Underlying Condition Occurrence Indicator
    │   │           ├── Comorbidity or Underlying Condition Specify Other Type
    │   │           └── Comorbidity or Underlying Condition Type
    │   ├──  Temperature (C25206) 
    │   │   └── Long-term storage temperature
    │   └──  Volume (C25335) 
    │       └──  Fluid Volume (C124480) 
    │           └──  Aliquot Volume (C171279) 
    │               └── Aliquot volume in mL
    ├──  Distance (C25167) 
    │   ├── Distance to Hospital Care in Miles
    │   ├── Distance to Routine Healthcare in Miles
    │   ├── Distance to Testing in Miles
    │   └── Distance to Testing in Time
    ├──  Equality (C61582) 
    │   └── Ability to Find Equivalent Job
    ├──  Health (C25178) 
    │   ├── COVID-19 Mental Health Symptom Type*
    │   ├── Confidence with Health Forms
    │   ├── Distance to Testing in Miles
    │   ├── Distance to Testing in Time
    │   └── SARS-CoV-2 Impact on Health Finding Type
    ├──  Location (C25341) 
    │   ├── SARS-CoV-2 Test Processing Location Type
    │   └── SARS-CoV-2 Test Specify Other Processing Location Type
    ├──  Person/Individual Attribute (C171087) 
    │   └──  Personal Attribute (C19332) 
    │       ├──  Ability (C78209) 
    │       │   ├── Ability to Find Equivalent Job
    │       │   └── Telework Eligibility Status
    │       ├──  Age (C25150) 
    │       │   ├── Age
    │       │   └── Age Units
    │       ├──  Birthplace (C176764) 
    │       │   ├── Birthplace Outside the US
    │       │   └── Birthplace US State
    │       ├──  Blood Type (C61009) 
    │       │   └── Blood Type
    │       ├──  Employment Status (C179143) 
    │       │   └──  Employed (C25172) 
    │       │       ├──  Telework (C180631) 
    │       │       │   └── Telework Eligibility Status
    │       │       ├── Employment Status
    │       │       └── Parent's Employment Status
    │       ├──  Looking for Work (C165487) 
    │       │   ├── Employment Status
    │       │   └── Parent's Employment Status
    │       ├──  Marital Status (C25188) 
    │       │   └── Marital Status
    │       ├──  National Origin (C28407) 
    │       │   └── Ancestry
    │       ├──  Quality of Life (C17047) 
    │       │   └── Quality of Life (QOL) Rating
    │       ├──  Sexual Orientation (C84361) 
    │       │   ├── Sexual Orientation Expanded Status
    │       │   ├── Sexual Orientation Specify Other Expanded Status
    │       │   ├── Sexual Orientation Status
    │       │   └── Sexual Orientation Status
    │       └──  Vital Status (C25717) 
    │           └── Patient Vital Status
    ├──  Primary Language Spoken (C132459) 
    │   └── Primary Language Spoken at home?
    ├──  Qualifier (C41009) 
    │   ├──  Anatomy Qualifier (C13442) 
    │   │   └──  Distal (C25237) 
    │   │       ├── Distance to Hospital Care in Miles
    │   │       ├── Distance to Routine Healthcare in Miles
    │   │       └── Distance to Testing in Miles
    │   ├──  Clinical or Research Assessment Answer (C91106) 
    │   │   ├──  Complete (C25250) 
    │   │   │   ├── Parent's Current Educational Attainment
    │   │   │   └── Parent's Current Educational Attainment
    │   │   ├──  Excellent (C82488) 
    │   │   │   └── Overall Health Condition
    │   │   ├──  Fair (C82489) 
    │   │   │   └── Overall Health Condition
    │   │   ├──  Fair Health (C157031) 
    │   │   │   └── Overall Health Condition
    │   │   ├──  Good (C64975) 
    │   │   │   └── Overall Health Condition
    │   │   ├──  Severe (C70667) 
    │   │   │   └── COVID-19 Disease Severity
    │   │   ├──  Usual (C102843) 
    │   │   │   └── Usual Place of Health Care Type*
    │   │   └──  Very Poor (C104315) 
    │   │       └── Overall Health Condition
    │   ├──  Disease Qualifier (C27992) 
    │   │   └──  Healthy (C115935) 
    │   │       └── Overall Health Condition
    │   ├──  General Qualifier (C27993) 
    │   │   ├──  Administered (C25382) 
    │   │   │   └── COVID-19 Vaccine Name
    │   │   ├──  Availability (C25429) 
    │   │   │   └── COVID-19 Vaccine Receptivity Status
    │   │   ├──  Condition (C25457) 
    │   │   │   └──  Medical Condition (C156809) 
    │   │   │       ├── Comorbidity or Underlying Condition Occurrence Indicator
    │   │   │       └── Comorbidity or Underlying Condition Type
    │   │   ├──  Consequence (C74555) 
    │   │   │   └── COVID-19 Mental Health Symptom Type*
    │   │   ├──  Done (C111784) 
    │   │   │   └── Lab Result Not Done Occurrence Indicator
    │   │   ├──  Easy (C86068) 
    │   │   │   └── Ability to Find Equivalent Job
    │   │   ├──  Emotional (C25495) 
    │   │   │   ├── Concentration Disability 
    │   │   │   └── Daily Activities Disability
    │   │   ├──  Exact (C86021) 
    │   │   │   └── Pre-Pandemic Monthly IncomeÂ Range
    │   │   ├──  Examined (C25500) 
    │   │   │   └── Major Classes of Metabolites Examined
    │   │   ├──  Full (C25517) 
    │   │   │   ├── Full Name
    │   │   │   └── Full Residential Address*
    │   │   ├──  Generalized (C63764) 
    │   │   │   └── Overall Health Condition
    │   │   ├──  Important (C115916) 
    │   │   │   └── Importance of Health Insurance in Seeking Care
    │   │   ├──  Major (C45368) 
    │   │   │   └── Major Classes of Metabolites Examined
    │   │   ├──  Present (C25626) 
    │   │   │   ├── Coinfection Present
    │   │   │   ├── Superinfection Present
    │   │   │   ├── Symptom Duration After Diagnosis Type 
    │   │   │   └── Symptom Duration Before Diagnosis Type
    │   │   ├──  Same (C64637) 
    │   │   │   └── Ability to Find Equivalent Job
    │   │   ├──  Treating (C25705) 
    │   │   │   ├── Treating Healthcare Facility Name
    │   │   │   └── Treating Healthcare Facility Name What is the facility name where the patient was treated?
    │   │   ├──  Underlying (C154417) 
    │   │   │   ├── Comorbidity or Underlying Condition Occurrence Indicator
    │   │   │   ├── Comorbidity or Underlying Condition Specify Other Type
    │   │   │   └── Comorbidity or Underlying Condition Type
    │   │   └──  Unknown (C17998) 
    │   │       ├── Medication Discontinued Date Unknown Indicator
    │   │       
    │   └──  Temporal Qualifier (C21514) 
    │       ├──  Date (C25164) 
    │       │   ├──  Birth Date (C68615) 
    │       │   │   └── Date of Birth*
    │       │   ├──  Collection Date (C81286) 
    │       │   │   └── Sample Collection Date
    │       │   ├──  Date of Death (C70810) 
    │       │   │   ├── Death Date
    │       │   │   └── Death Date Indicator
    │       │   ├──  End Date (C68617) 
    │       │   │   └──  Adverse Event End Date (C78537) 
    │       │   │       └── Adverse Event End Date 
    │       │   ├──  Expected Date of Confinement (C81247) 
    │       │   │   └── Current Pregnancy Due Date
    │       │   ├──  Informed Consent Date (C93579) 
    │       │   │   ├── Informed Consent Signed Date
    │       │   │   └── Informed Consent Signed Date N/A or Not Reported Indicator
    │       │   ├──  Onset Date (C93613) 
    │       │   │   ├──  Symptom Onset Date (C119242) 
    │       │   │   │   └── Self-Reported COVID-19 Symptom Onset Date Indicator
    │       │   │   ├── COVID-19 Complication Onset Date
    │       │   │   └── COVID-19 Complication Onset Date Indicator
    │       │   ├──  Start Date (C68616) 
    │       │   │   └──  Adverse Event Start Date (C78536) 
    │       │   │       └── Adverse Event Start Date
    │       │   ├──  Test Date (C82512) 
    │       │   │   └── SARS-CoV-2 Test Date and Time
    │       │   ├── COVID-19 Complication Onset Date
    │       │   ├── COVID-19 Complication Onset Date Indicator
    │       │   ├── Date of Chest Examination
    │       │   ├── Discharge Date
    │       │   ├── Hospitalization Date*
    │       │   ├── Informed Consent Signed Date N/A or Not Reported Indicator
    │       │   ├── Lab Result Date
    │       │   ├── Recent Travel Date of Arrival in the 14 days prior to onset of symptoms or illness
    │       │   ├── Recent Travel Date of Return in the 14 days prior to onset of symptoms or illness
    │       │   ├── SARS-CoV-2 Test Date of Result
    │       │   └── Sample Collection Date
    │       ├──  Date and Time (C37939) 
    │       │   └── SARS-CoV-2 Test Date and Time Indicator
    │       ├──  Duration (C25330) 
    │       │   ├── Fever Duration
    │       │   ├── Fever Duration
    │       │   └── Symptom Duration After Diagnosis Value
    │       ├──  Long-Term (C25322) 
    │       │   └── Long-term storage temperature
    │       ├──  Now (C65002) 
    │       │   └── Current Pregnancy Indicator
    │       ├──  Onset (C25279) 
    │       │   └──  Symptom Onset (C124353) 
    │       │       └── Travel History in 14 days prior to onset of symptoms or illness
    │       ├──  Past (C25609) 
    │       │   ├── Cost Delayed Healthcare Occurrence Indicator
    │       │   └── Delayed Healthcare Due to Transportation Indicator
    │       ├──  Period (C25616) 
    │       │   ├──  12 Months (C156842) 
    │       │   │   ├── Cost Delayed Healthcare Occurrence Indicator
    │       │   │   ├── Delayed Healthcare Due to Transportation Indicator
    │       │   │   └── Job Insecurity in 12 Months
    │       │   └──  Past 30 days (C131330) 
    │       │       └── Current Medication Name
    │       ├──  Prior (C25629) 
    │       │   ├── Recent Travel Date of Return in the 14 days prior to onset of symptoms or illness
    │       │   ├── Symptom Duration Before Diagnosis Type
    │       │   ├── Travel History in 14 days prior to onset of symptoms or illness
    │       │   └── Travel History in 14 days prior to onset of symptoms or illness
    │       ├──  Recent (C25280) 
    │       │   ├── Recent Travel Date of Arrival in the 14 days prior to onset of symptoms or illness
    │       │   └── Recent Travel Date of Return in the 14 days prior to onset of symptoms or illness
    │       ├──  Time (C25207) 
    │       │   ├──  Collection Time (C81287) 
    │       │   │   ├──  Biospecimen Collection Time (C178869) 
    │       │   │   │   └── COVID-19 Symptoms At Time of Testing Indicator
    │       │   │   └── Minutes until sample collected reaches the freezer 
    │       │   ├──  End Time (C82573) 
    │       │   │   └──  Adverse Event End Time (C83046) 
    │       │   │       └── Adverse Event End Time
    │       │   ├──  Start Time (C78441) 
    │       │   │   └──  Adverse Event Start Time (C78539) 
    │       │   │       └── Adverse Event Start Time
    │       │   ├──  Test Time (C82577) 
    │       │   │   ├── Distance to Testing in Time
    │       │   │   └── SARS-CoV-2 Test Date and Time
    │       │   ├──  Vital Signs Time (C83155) 
    │       │   │   └── Vital Signs Date and Time
    │       │   ├── Comorbidity or Underlying Condition Type
    │       │   ├── SARS-CoV-2 Risk Behavior Type
    │       │   ├── Time from COVID Symptom Onset to Hospitalization
    │       │   └── Time from COVID Symptom Onset to Hospitalization Unit of Measure
    │       └──  Timepoint (C68568) 
    │           └──  Vital Signs Time Point (C83159) 
    │               ├── Vital Signs Specify Other Timepoint
    │               └── Vital Signs Timepoint
    ├──  Qualitative Concept (C92722) 
    │   ├──  Data Type (C42645) 
    │   │   └──  Long (C48311) 
    │   │       └── Fever Duration
    │   └── COVID-19 Vaccine Receptivity Status
    ├──  Quality (C25283) 
    │   ├── Metabolomics Quality Control Measures
    │   └── Metabolomics Quality Control Measures Occurrence Indicator
    ├──  Quantity (C25256) 
    │   └── Pre-Pandemic Monthly Income  Range
    ├──  Status (C25688) 
    │   ├──  Health Status (C16669) 
    │   │   ├──  Disability (C21007) 
    │   │   │   ├── Concentration Disability 
    │   │   │   ├── Daily Activities Disability
    │   │   │   ├── Hearing Disability 
    │   │   │   ├── Pre-Pandemic Monthly Income Amount
    │   │   │   ├── Pre-Pandemic Monthly Income Range
    │   │   │   └── Washing and Dressing Disability 
    │   │   ├──  Individual Physical Condition (C106492) 
    │   │   │   ├── Concentration Disability 
    │   │   │   └── Daily Activities Disability
    │   │   └──  Patient Status (C166244) 
    │   │       └── Patient Status
    │   ├── Patient Specify Other Status
    │   └── Patient Specify Other Status Specify other patient type
    ├──  Temporal Frequency (C25515) 
    │   └── Current Medication Dose Frequency
    └──  Unit of Measure (C25709) 
        ├──  Unit by Category (C42568) 
        │   ├──  Age Unit (C50400) 
        │   │   ├──  Day (C25301) 
        │   │   │   ├── Days Hospitalized 
        │   │   │   └── Days in Intensive Care Unit 
        │   │   └──  Year (C29848) 
        │   │       └── Years at Residence
        │   ├──  Unit of Length (C42578) 
        │   │   └──  Mile Unit of Distance (C71181) 
        │   │       └──  Mile (C71183) 
        │   │           ├── Distance to Hospital Care in Miles
        │   │           ├── Distance to Routine Healthcare in Miles
        │   │           └── Distance to Testing in Miles
        │   └──  Unit of Time (C42574) 
        │       └──  Minute (C48154) 
        │           └── Minutes until sample collected reaches the freezer 
        ├── Age Units
        ├── Current Medication Dose Unit of Measure
        ├── Fever Duration Unit of Measure
        ├── Symptom Duration After Diagnosis Unit of Measure
        ├── Symptom Duration Before Diagnosis Unit of Measure
        ├── Time from COVID DX to Hospitalization Unit of Measure
        └── Time from COVID Symptom Onset to Hospitalization Unit of Measure
